Piper Jaffray Expands Medical Technology Investment Research Team

  
    
  
  
    
      Piper Jaffray announced it has expanded its investment research medical 
      technology team with the addition of Tim Lee as a senior research 
      analyst. He will be based in the firm’s San 
      Francisco office and provide coverage of companies in the medical 
      technology sector, allowing the firm to build on its leading health care 
      research franchise.
    
    
      Lee joins Piper Jaffray with more than 10 years of experience working 
      for companies including Kaufman Brothers, Merrill Lynch, SG Cowen and 
      Salomon Brothers. He was previously a managing director covering the 
      medical technology sector at Caris & Company. Lee earned a bachelor’s 
      degree from the University of the Pacific and a Master of Business 
      Administration degree from the Kelley School of Business from Indiana 
      University.
    
    
      “We continue to bring quality health care 
      analysts to our investment research team at Piper Jaffray and Tim is no 
      exception,” says Joel Denney, head of 
      investment research at Piper Jaffray. “He will 
      be a great addition to the medical technology team as we continue to 
      build on our reputation as an industry leader in the health care sector.”
    
    
      In working with hospitals, health care systems, physician groups and 
      HMOs, Piper Jaffray has built a leading position in U.S. health care, 
      and has also quickly built a reputation as one of the leading investment 
      banks in European health care. The firm has ranked as the top IPO 
      underwriter and M&A advisor in the health care industry since 2005(a).
    
    
      In addition, Piper Jaffray provides research coverage in the following 
      health care sub-sectors: biotechnology: biopharmaceuticals; 
      biotechnology: therapeutics; China healthcare; drug discovery; European 
      biotechnology; European medical technology; health care services: 
      information technology; life science tools; medical diagnostics; medical 
      technology; and specialty pharmaceuticals.
    
    
      (a) Source: Thomson Financial Securities Data; Dealogic
    
    
      About Piper Jaffray
    
    
      Piper Jaffray Companies is a leading, international middle-market 
      investment bank and institutional securities firm, serving the needs of 
      middle-market corporations, private equity groups, public entities, 
      nonprofit clients and institutional investors. Founded in 1895, Piper 
      Jaffray provides a comprehensive set of products and services, including 
      equity and debt capital markets products; public finance services; 
      mergers and acquisitions advisory services; high-yield and structured 
      products; institutional equity and fixed-income sales and trading; and 
      equity and high-yield research. With headquarters in Minneapolis, Piper 
      Jaffray has 25 offices across the United States and international 
      locations in London, Hong Kong, and Shanghai. Piper Jaffray & Co. is the 
      firm's principal operating subsidiary. (NYSE: PJC) (http://www.piperjaffray.com)
    
    
      Since 1895. Member SIPC and FINRA.
    
    
      © 2008 Piper Jaffray & Co., 800 Nicollet Mall, 
      Suite 800, Minneapolis, Minnesota 55402-7020